Invitation to SynAct Pharma’s Capital Markets Day in Stockholm March 11
Prenumeration
Beskrivning
| Land | Sverige |
|---|---|
| Lista | Small Cap Stockholm |
| Sektor | Hälsovård |
| Industri | Bioteknik |
Intresserad av bolagets nyckeltal?
Analysera bolaget i Börsdata!
Vem äger bolaget?
All ägardata du vill ha finns i Holdings!
SynAct Pharma AB (“SynAct”) (Nasdaq Stockholm: SYNACT), a clinical-stage biotechnological company focused on treating inflammation through resolution, invites investors, analysts and media to a Capital Markets Day on Wednesday, March 11, 15:00-17:00 CET in Stockholm.
SynAct is entering a transformational stage as the company expects clinical data from the company’s Phase 2b ADVANCE study in patients with newly diagnosed severe rheumatoid arthritis (RA) in Q2 and expands its development pipeline in viral-induced inflammation programs. Please join the CMD to hear about SynAct’s efforts and path forward.
Agenda
15:00–15:10 Welcome and Corporate Update (Jeppe Øvlesen, CEO)
15:10–16:00 Resolution Therapy: A Novel Approach in Rheumatoid Arthritis
- 15:10–15:25 Professor Philip Conaghan, M.D., Director of NIHR Leeds Biomedical Research Centre
- 15:25–15:40 How resomelagon works and the rationale for a safe and effective therapy (Thomas Jonassen, CSO)
- 15:40–15:50 Market overview and deal scenario (Mads Bjerregaard, CBO)
- 15:50–16:00 Q&A
16:00–16:45 Resolution Therapy: A Novel Approach in Respiratory Infections
- 16:00–16:15 Professor Thomas Benfield, M.D., Director of Center for Clinical Research & Disruption of Infectious Diseases (CREDID), Copenhagen University Hospital – Amager and Hvidovre
- 16:15–16:25 Preclinical rationale, the RESPIRE trial, and beyond (Thomas Jonassen, CSO)
- 16:25–16:35 Market overview and deal scenario (Mads Bjerregaard, CBO)
- 16:35–16:45 Q&A
16:45–16:55 Financial and Business Development (Ann Kristin Led, CFO; Mads Bjerregaard, CBO)
16:55–17:00 Looking ahead and end of meeting (Jeppe Øvlesen, CEO)
When: March 11, 2026, from 15:00–17:00 CET
Location: Investor Studios, Hötorgsskrapan 3
Address: Sveavägen 9 or Mäster Samuelsgatan 42 or Sergelgatan 8–10, Floor 7
Additional information:
If you enter the building via Sveavägen 9 or Sergelgatan 8–10, choose the escalator, turn to the left after entering the next floor and choose the elevator in front of you (floor 7).
If you enter the building via Mäster Samuelsgatan 42, go straight ahead and pass the reception and continue towards the elevators you see in front of you (floor 7).
Follow the broadcast live here:
https://www.youtube.com/live/aVmsHexj9KE
The Capital Markets Day will be held in English. Presentation material will be available on SynAct’s website afterwards.
Registration for the event is made by mailing investor.relations@synactpharma.com